Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Adenocarcinoma of Lung × anlotinib × Clear all

Phase

Status

Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 6 Neoplasms 5 Neoplasm Metastasis 2 Nasopharyngeal Carcinoma 2 Esophageal Neoplasms 2 Colorectal Neoplasms 2 Breast Neoplasms 2 Thyroid Neoplasms 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Recurrence 1 Platinum-resistant Recurrent Clear Cell Ovarian Cancer 1 Pancreatic Neoplasms 1 NSCLC 1 Lung Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Medullary 1 Brain Neoplasms 1 Advanced Solid Tumors 1 Advanced Malignancy 1 Advanced Cancer 1 Adenocarcinoma of Lung 1

Interventions

Carboplatin 34 Paclitaxel 27 Radiotherapy 24 Bevacizumab 23 Cisplatin 22 Pemetrexed 18 Erlotinib Hydrochloride 16 Gemcitabine 15 Docetaxel 15 Cetuximab 7 Gefitinib 6 Vinorelbine 5 Surgical Procedures, Operative 5 ceritinib 4 Taxes 4 Etoposide 4 sargramostim 3 pembrolizumab 3 Radiotherapy, Conformal 3 Gene Expression Profiling 3 Cyclophosphamide 3 Amplified Fragment Length Polymorphism Analysis 3 2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a 3 trametinib 2 osimertinib 2 capmatinib 2 Topotecan 2 Temozolomide 2 Sorafenib 2 Radiotherapy, Intensity-Modulated 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04770688 2024-08-15

AUTOMAN

Shanghai Chest Hospital

Phase 1/2 Completed

Adenocarcinoma of Lung, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡